Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-04-09 @ 9:04 PM
Study NCT ID:
NCT01025232
Status:
TERMINATED
Last Update Posted:
2017-01-02
First Post:
2009-12-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Sponsor:
David M. Brown, M.D.
Organization:
Conditions & Keywords Data
Conditions: